NCT01440764View on ClinicalTrials.gov

Aerosol Inhalation Treatment for Dyspnea

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2017

Conditions
HealthyDyspnea
Interventions
DRUG

Furosemide

DRUG

Saline

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

National Institute of Nursing Research (NINR)

NIH

lead

Beth Israel Deaconess Medical Center

OTHER

NCT01440764 - Aerosol Inhalation Treatment for Dyspnea | Biotech Hunter | Biotech Hunter